Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

INTRODUCTION: Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi typhoid conjugate vaccine (TCV) can protect adults against Salmonella Typhi infections. TCVs offer better protection than Vi-PS in infants and may offer better protection in adults. Potential reasons for why TCV may be s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jossi, Siân E., Arcuri, Melissa, Alshayea, Areej, Persaud, Ruby R., Marcial-Juárez, Edith, Palmieri, Elena, Di Benedetto, Roberta, Pérez-Toledo, Marisol, Pillaye, Jamie, Channell, Will M., Schager, Anna E., Lamerton, Rachel E., Cook, Charlotte N., Goodall, Margaret, Haneda, Takeshi, Bäumler, Andreas J., Jackson-Jones, Lucy H., Toellner, Kai-Michael, MacLennan, Calman A., Henderson, Ian R., Micoli, Francesca, Cunningham, Adam F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076549/
https://www.ncbi.nlm.nih.gov/pubmed/37033932
http://dx.doi.org/10.3389/fimmu.2023.1139329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076549/
https://www.ncbi.nlm.nih.gov/pubmed/37033932
http://dx.doi.org/10.3389/fimmu.2023.1139329

Ejemplares similares